Title |
Interventions to decrease the risk of adverse cardiac events for post-surgery or chemotherapy patients taking serotonin (5-HT3) receptor antagonists: protocol for a systematic review and network meta-analysis
|
---|---|
Published in |
Systematic Reviews, June 2013
|
DOI | 10.1186/2046-4053-2-45 |
Pubmed ID | |
Authors |
Andrea C Tricco, Charlene Soobiah, Jesmin Antony, Brenda Hemmelgarn, David Moher, Brian Hutton, Sharon E Straus |
Abstract |
Patients undergoing surgery or chemotherapy often experience nausea and vomiting. To increase their quality of life and treatment satisfaction, antiemetic medication, such as serotonin receptor antagonists, is often prescribed for patients experiencing these symptoms. However, early warning signs suggest that serotonin receptor antagonists can cause harm, including arrhythmia. Our objective is to identify the most effective interventions that mitigate the risk of adverse cardiac events associated with serotonin receptor antagonists in patients undergoing surgery and chemotherapy through a systematic review and network meta-analysis. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Colombia | 1 | 2% |
Unknown | 46 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 7 | 15% |
Student > Master | 7 | 15% |
Student > Doctoral Student | 5 | 11% |
Student > Bachelor | 5 | 11% |
Student > Ph. D. Student | 4 | 9% |
Other | 12 | 26% |
Unknown | 7 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 17 | 36% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 9% |
Economics, Econometrics and Finance | 4 | 9% |
Nursing and Health Professions | 2 | 4% |
Biochemistry, Genetics and Molecular Biology | 2 | 4% |
Other | 7 | 15% |
Unknown | 11 | 23% |